SLXN
Silexion Therapeutics Corp
Company overview
- Market capitalization
- $1.38M
- Employees
- 13
- Latest publication
- 2026-09-29
About Silexion Therapeutics Corp
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 2,000USD | 3,000USD | 4,000USD | 3,000USD | 4,000USD | — | 22,000USD | 7,000USD |
| Gross Profit | -2,000USD | -3,000USD | -4,000USD | -3,000USD | -4,000USD | — | -22,000USD | -7,000USD |
| Research Development | 1,370,000USD | 3,375,000USD | 2,157,000USD | 1,018,000USD | 590,000USD | 871USD | 3,217,000USD | 766,000USD |
| Selling General Administrative | 1,379,000USD | 1,028,000USD | 1,131,000USD | 1,263,000USD | 1,056,000USD | 12,483USD | 4,797,000USD | 612,000USD |
| Total Operating Expenses | 2,747,000USD | -18,858,000USD | 3,288,000USD | 2,284,000USD | 1,650,000USD | 23,242USD | 8,036,000USD | 1,385,000USD |
| Operating Income | -2,749,000USD | 18,858,000USD | -3,292,000USD | -2,284,000USD | -1,650,000USD | -23,242USD | -8,036,000USD | -1,385,000USD |
| Interest Income | 32,000USD | 69,000USD | 39,000USD | 43,000USD | — | 24,000USD | 0USD | 6,000USD |
| Net Interest Income | 43,000USD | 313,000USD | 62,000USD | 43,000USD | -91,000USD | -26,000USD | -4,838,000USD | 4,000USD |
| Income Before Tax | -2,733,000USD | -4,412,000USD | -3,262,000USD | -2,500,000USD | -1,735,000USD | -31,272USD | -11,858,000USD | -1,487,000USD |
| Net Income | -2,733,000USD | -4,412,000USD | -3,262,000USD | -2,503,000USD | -1,735,000USD | -31,139USD | -11,851,000USD | -1,472,000USD |
| Net Income From Continuing Ops | -2,733,000USD | -4,412,000USD | -3,262,000USD | -2,503,000USD | -1,735,000USD | -1,747,000USD | -11,860,000USD | -1,489,000USD |
| Ebit | -2,749,000USD | -4,406,000USD | -3,262,000USD | -2,500,000USD | -1,726,000USD | -23,241USD | -8,036,000USD | -1,485,000USD |
| Ebitda | -2,747,000USD | -4,403,000USD | -3,258,000USD | -2,497,000USD | -1,722,000USD | -23,235USD | -8,014,000USD | -1,478,000USD |
| Depreciation And Amortization | 2,000USD | 3,000USD | 4,000USD | 3,000USD | 4,000USD | 6USD | 22,000USD | 7,000USD |
| Reconciled Depreciation | 2,000USD | 3,000USD | 4,000USD | 3,000USD | 4,000USD | -12,000USD | 22,000USD | 7,000USD |
| Total Other Income Expense Net | 16,000USD | -23,270,000USD | 30,000USD | -216,000USD | -85,000USD | 154,000USD | -3,822,000USD | -102,000USD |
| Unclassified Operating Expenses | — | -23,261,000USD | — | — | — | — | — | — |
| Interest Expense | — | 6,000USD | 4,000USD | 0USD | 9,000USD | — | 52,000USD | 2,000USD |
| Tax Provision | — | 0USD | 0USD | 3,000USD | — | 1,000USD | 2,000USD | 2,000USD |
| Minority Interest | — | 0USD | 0USD | 0USD | 0USD | 0USD | 9,000USD | 17,000USD |
| Income Tax Expense | — | — | — | 3,000USD | — | 19USD | 2,000USD | 2,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 7,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | — | — | — |
| Cost Of Revenue | 14,000USD | 25,000USD | — | — | — | — | — |
| Gross Profit | -14,000USD | -25,000USD | — | — | — | — | — |
| Research Development | 7,140,000USD | 5,815,000USD | 3,708,000USD | 3,226,000USD | — | — | — |
| Selling General Administrative | 4,478,000USD | 6,731,000USD | 928,000USD | 577,000USD | — | — | — |
| Unclassified Operating Expenses | -23,250,000USD | — | — | — | — | — | — |
| Total Operating Expenses | -11,632,000USD | 12,571,000USD | 4,681,000USD | 3,860,000USD | 943,933USD | 195,860USD | — |
| Operating Income | 11,632,000USD | -12,571,000USD | -4,681,000USD | -3,860,000USD | -943,933USD | -195,860USD | — |
| Interest Income | 142,000USD | 1,000USD | 153,000USD | 114,000USD | — | — | — |
| Interest Expense | 13,000USD | 52,000USD | 9,000USD | 85,000USD | — | — | — |
| Net Interest Income | 129,000USD | -4,841,000USD | 144,000USD | 29,000USD | — | — | — |
| Income Before Tax | -11,909,000USD | -16,509,000USD | -5,076,000USD | -3,464,000USD | -755,218USD | -195,860USD | — |
| Income Tax Expense | 3,000USD | 10,000USD | 32,000USD | 24,000USD | — | — | — |
| Tax Provision | 3,000USD | 10,000USD | 32,000USD | 24,000USD | — | — | — |
| Net Income | -11,912,000USD | -16,443,000USD | -4,942,000USD | -3,215,000USD | -755,218USD | -195,860USD | — |
| Net Income From Continuing Ops | -11,912,000USD | -16,519,000USD | -5,108,000USD | -3,488,000USD | — | — | — |
| Ebit | -11,896,000USD | -16,502,000USD | -4,681,000USD | -3,860,000USD | -943,933USD | -196,000USD | -953,000USD |
| Ebitda | -11,882,000USD | -16,477,000USD | -4,636,000USD | -3,803,000USD | -755,000USD | -195,860USD | — |
| Depreciation And Amortization | 14,000USD | 25,000USD | 45,000USD | 57,000USD | — | — | — |
| Reconciled Depreciation | 14,000USD | 25,000USD | 45,000USD | 57,000USD | — | — | — |
| Total Other Income Expense Net | -23,541,000USD | -3,938,000USD | -395,000USD | 396,000USD | 188,715USD | — | — |
| Minority Interest | 0USD | 76,000USD | 166,000USD | 273,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | -938,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4,246,000USD | 4,602,000USD | 7,215,000USD | 11,614,000USD | 5,797,000USD | 8,308,000USD | 2,863,000USD | 3,087,000USD |
| Cash And Equivalents | 2,229,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 3,741,000USD | 4,065,000USD | 6,637,000USD | 11,055,000USD | 5,237,000USD | 7,722,000USD | 2,250,000USD | 3,047,000USD |
| Other Current Assets | 111,000USD | 1,652,000USD | 646,000USD | 1,812,000USD | 1,771,000USD | 1,570,000USD | 1,063,000USD | 1,074,000USD |
| Total Liabilities | 4,202,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,976,000USD | 4,060,000USD | 2,758,000USD | 2,786,000USD | 2,150,000USD | 2,395,000USD | 3,523,000USD | 3,583,000USD |
| Other Current Liabilities | 933,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 44,000USD | 291,000USD | 2,603,000USD | 6,977,000USD | 120,000USD | 2,586,000USD | -3,989,000USD | -4,579,000USD |
| Total Equity Including Noncontrolling Interest | 44,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 368,000USD | 403,000USD | 437,000USD | 468,000USD | 502,000USD | 534,000USD | 560,000USD | 35,000USD |
| Accounts Payable | 1,180,000USD | 912,000USD | 787,000USD | 946,000USD | 692,000USD | 722,000USD | 929,000USD | 799,000USD |
| Short Term Debt | 199,000USD | 185,000USD | 182,000USD | 174,000USD | 171,000USD | 155,000USD | 1,162,000USD | 229,000USD |
| Common Stock | 160,000USD | 46,000USD | 42,000USD | 42,000USD | 8,000USD | 8,000USD | 2,000USD | 1,000USD |
| Retained Earnings | -61,450,000USD | -57,899,000USD | -55,166,000USD | -50,754,000USD | -47,492,000USD | -44,989,000USD | -43,254,000USD | -41,583,000USD |
| Total Liab | — | 4,311,000USD | 4,612,000USD | 4,637,000USD | 5,677,000USD | 5,722,000USD | 6,852,000USD | 7,666,000USD |
| Other Current Liab | — | 2,963,000USD | 1,789,000USD | 2,612,000USD | 1,287,000USD | 1,518,000USD | 1,432,000USD | 2,555,000USD |
| Capital Stock | — | 46,000USD | 42,000USD | 42,000USD | 8,000USD | 8,000USD | 2,000USD | 1,000USD |
| Cash | — | 2,413,000USD | 5,991,000USD | 9,243,000USD | 3,466,000USD | 6,152,000USD | 1,187,000USD | 1,973,000USD |
| Cash And Short Term Investments | — | 2,413,000USD | 5,991,000USD | 9,243,000USD | 3,466,000USD | 6,152,000USD | 1,187,000USD | 1,973,000USD |
| Net Debt | — | -1,977,000USD | -5,523,000USD | -8,758,000USD | 232,000USD | -2,670,000USD | 3,304,000USD | 2,339,000USD |
| Short Long Term Debt | — | 1,553,000USD | — | — | — | — | 1,004,000USD | 229,000USD |
| Short Long Term Debt Total | — | 436,000USD | 468,000USD | 485,000USD | 3,698,000USD | 3,482,000USD | 4,491,000USD | 4,312,000USD |
| Property Plant Equipment Gross | — | 403,000USD | 520,000USD | 468,000USD | 502,000USD | 534,000USD | 629,000USD | 35,000USD |
| Common Stock Shares Outstanding | — | 323,037shares | 312,665shares | 113,266shares | 57,952shares | 677,921shares | 924,356shares | 647,567shares |
| Non Current Assets Total | — | 537,000USD | 578,000USD | 559,000USD | 560,000USD | 586,000USD | 613,000USD | 40,000USD |
| Non Current Liabilities Total | — | 251,000USD | 1,854,000USD | 1,851,000USD | 3,527,000USD | 3,327,000USD | 3,329,000USD | 4,083,000USD |
| Non Currrent Assets Other | — | 76,000USD | 84,000USD | 91,000USD | 5,000USD | 5,000USD | 53,000USD | 5,000USD |
| Net Working Capital | — | 5,000USD | 3,879,000USD | 8,269,000USD | 3,087,000USD | 5,327,000USD | -1,273,000USD | -536,000USD |
| Unclassified Current Liabilities | — | -1,553,000USD | — | — | — | — | -1,004,000USD | — |
| Unclassified Equity | — | 58,098,000USD | 57,685,000USD | 57,647,000USD | 47,596,000USD | 47,559,000USD | 39,261,000USD | 37,002,000USD |
| Long Term Debt | — | — | 1,568,000USD | 1,540,000USD | 3,190,000USD | 2,993,000USD | 2,961,000USD | 4,083,000USD |
| Short Term Investments | — | — | — | — | — | — | 35,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 7,215,000USD | 2,863,000USD | 5,256,000USD | 9,333,000USD | 115,414,169USD | 129,399USD | — | — |
| Other Current Assets | 646,000USD | 1,063,000USD | 384,000USD | 580,000USD | 368,853USD | — | 38,000USD | 29,000USD |
| Total Liab | 4,612,000USD | 6,852,000USD | 17,312,000USD | 16,412,000USD | 508,916USD | 299,390USD | — | — |
| Total Stockholder Equity | 2,603,000USD | -3,989,000USD | -15,476,000USD | -10,665,000USD | 114,905,252USD | -169,990USD | — | — |
| Other Current Liab | 1,789,000USD | 1,432,000USD | 1,765,000USD | 1,255,000USD | 348,576USD | 29,400USD | — | — |
| Common Stock | 42,000USD | 2,000USD | 1,000USD | 1,000USD | 115,000,336USD | 298USD | — | — |
| Capital Stock | 42,000USD | 2,000USD | 1,000USD | 1,000USD | — | — | — | — |
| Retained Earnings | -55,166,000USD | -43,254,000USD | -26,811,000USD | -21,869,000USD | -951,078USD | -195,860USD | -4,468,000USD | -3,113,000USD |
| Cash | 5,991,000USD | 1,187,000USD | 4,595,000USD | 8,259,000USD | 38,944USD | 51,701USD | — | — |
| Cash And Short Term Investments | 5,991,000USD | 1,187,000USD | 4,595,000USD | 8,259,000USD | 38,944USD | 51,701USD | — | — |
| Total Current Assets | 6,637,000USD | 2,250,000USD | 4,979,000USD | 8,839,000USD | 407,797USD | 51,701USD | 928,000USD | 1,788,000USD |
| Total Current Liabilities | 2,758,000USD | 3,523,000USD | 2,196,000USD | 1,610,000USD | 348,576USD | 29,400USD | 241,000USD | 168,000USD |
| Net Debt | -5,523,000USD | 3,304,000USD | -4,424,000USD | -7,988,000USD | -38,944USD | -51,701USD | — | — |
| Short Term Debt | 182,000USD | 1,162,000USD | 112,000USD | 115,000USD | — | — | — | — |
| Short Long Term Debt Total | 468,000USD | 4,491,000USD | 171,000USD | 271,000USD | — | — | — | — |
| Long Term Debt | 1,568,000USD | 2,961,000USD | — | — | — | — | — | — |
| Accounts Payable | 787,000USD | 929,000USD | 319,000USD | 240,000USD | — | — | 102,000USD | 81,000USD |
| Property Plant Equipment Net | 437,000USD | 560,000USD | 247,000USD | 464,000USD | — | — | 9,000USD | 7,000USD |
| Property Plant Equipment Gross | 520,000USD | 629,000USD | 334,000USD | 703,000USD | — | — | — | — |
| Common Stock Shares Outstanding | 132,951shares | 623,846shares | 111,726shares | 1,672,777shares | 1,650,555shares | 1,650,555shares | — | — |
| Non Current Assets Total | 578,000USD | 613,000USD | 277,000USD | 494,000USD | 115,006,372USD | 77,698USD | — | — |
| Non Current Liabilities Total | 1,854,000USD | 3,329,000USD | 15,116,000USD | 14,802,000USD | 160,340USD | 269,990USD | — | — |
| Non Currrent Assets Other | 84,000USD | 53,000USD | 30,000USD | 30,000USD | — | 77,698USD | — | — |
| Net Working Capital | 3,879,000USD | -1,273,000USD | 2,783,000USD | 7,229,000USD | — | — | — | — |
| Unclassified Equity | 57,685,000USD | 39,261,000USD | 11,333,000USD | 11,202,000USD | — | — | — | — |
| Short Long Term Debt | — | 1,004,000USD | — | — | — | — | — | — |
| Short Term Investments | — | 35,000USD | — | — | — | — | — | — |
| Unclassified Current Liabilities | — | -1,004,000USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | — | 15,116,000USD | 14,802,000USD | — | — | — | — |
| Unclassified Non Current Assets | — | — | — | — | 115,006,372USD | — | — | — |
| Net Receivables | — | — | — | — | — | — | 89,000USD | 161,000USD |
| Net Tangible Assets | — | — | — | — | — | — | 696,000USD | 1,627,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | 1,598,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 3,000USD | 2,000USD | 3,000USD | 4,000USD | 3,000USD | 4,000USD | -12,000USD | 22,000USD |
| Stock Based Compensation | 197,000USD | 345,000USD | 38,000USD | 38,000USD | 37,000USD | 21,000USD | 31,968USD | 5,798,000USD |
| Other Non Cash Items | 135,000USD | 4,000USD | 88,000USD | -16,000USD | 229,000USD | 81,000USD | -251,968USD | 3,817,000USD |
| Change In Working Capital | 68,000USD | -1,264,000USD | 1,305,000USD | 393,000USD | -273,000USD | -824,000USD | -947,000USD | -430,000USD |
| Operating Cash Flow | -2,925,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | 0USD | 0USD | -2,000USD | 0USD | -1,000USD | -6,000USD | 0USD | -16,000USD |
| Unclassified Investing Cash Flow | -1,000USD | — | — | — | — | — | — | — |
| Investing Cash Flow | -1,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 2,740,000USD | — | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | 8,000USD | — | — | — | — | — | — | — |
| Change In Cash | -178,000USD | -3,577,000USD | -3,251,000USD | 5,778,000USD | -2,689,000USD | 4,963,000USD | -753,000USD | 276,000USD |
| End Cash Flow | 2,320,000USD | — | — | — | — | — | — | — |
| Net Income | — | -2,733,000USD | -4,412,000USD | -3,262,000USD | -2,503,000USD | -1,735,000USD | -1,747,000USD | -11,860,000USD |
| Total Cash From Operating Activities | — | -3,646,000USD | -3,016,000USD | -2,843,000USD | -2,507,000USD | -2,453,000USD | -2,926,000USD | -2,653,000USD |
| Free Cash Flow | — | -3,646,000USD | -3,018,000USD | -2,843,000USD | -2,508,000USD | -2,459,000USD | -2,926,000USD | -2,669,000USD |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | -696,000USD | — | 0USD |
| Total Cash From Financing Activities | — | 83,000USD | -221,000USD | 8,624,000USD | -195,000USD | 7,432,000USD | 2,184,000USD | 2,920,000USD |
| Issuance Of Capital Stock | — | 83,000USD | 2,644,000USD | 7,760,000USD | 0USD | 5,000,000USD | 2,434,000USD | 620,000USD |
| Begin Period Cash Flow | — | 6,075,000USD | 9,269,000USD | 3,491,000USD | 6,233,000USD | 1,270,000USD | 2,023,000USD | 1,747,000USD |
| End Period Cash Flow | — | 2,498,000USD | 6,018,000USD | 9,269,000USD | 3,544,000USD | 6,233,000USD | 1,270,000USD | 2,023,000USD |
| Other Cashflows From Financing Activities | — | 83,000USD | — | — | — | 3,128,000USD | -250,000USD | 2,805,000USD |
| Total Cashflows From Investing Activities | — | — | -7,000USD | — | -1,000USD | -6,000USD | — | -16,000USD |
| Unclassified Financing Cash Flow | — | — | -2,865,000USD | — | — | — | — | — |
| Change To Account Receivables | — | — | — | 16,000USD | — | 4,000USD | — | — |
| Investments | — | — | — | 0USD | -1,000USD | -6,000USD | 0USD | -16,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 5,000USD |
| Stock Based Compensation | 542,000USD |
| Other Non Cash Items | 131,000USD |
| Change In Working Capital | -251,000USD |
| Operating Cash Flow | -6,571,000USD |
| Capital Expenditures | 0USD |
| Unclassified Investing Cash Flow | -1,000USD |
| Investing Cash Flow | -1,000USD |
| Financing Cash Flow | 2,823,000USD |
| Effect Of Forex Changes On Cash | -6,000USD |
| Change In Cash | -3,755,000USD |
| End Cash Flow | 2,320,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -11,912,000USD | -16,519,000USD | -5,108,000USD | -3,488,000USD | -755,218USD | -195,860USD | -938,000USD |
| Depreciation | 14,000USD | 25,000USD | 45,000USD | 57,000USD | — | — | 2,000USD |
| Stock Based Compensation | 134,000USD | 5,862,000USD | 130,000USD | 125,000USD | — | — | — |
| Other Non Cash Items | 344,000USD | 3,816,000USD | 317,000USD | -268,000USD | -182,343USD | — | — |
| Change In Working Capital | 601,000USD | -1,580,000USD | 87,000USD | 239,000USD | -469,675USD | 120,860USD | -42,000USD |
| Total Cash From Operating Activities | -10,819,000USD | -8,396,000USD | -4,529,000USD | -3,335,000USD | -1,407,236USD | -75,000USD | -911,000USD |
| Capital Expenditures | -9,000USD | -22,000USD | -12,000USD | -40,000USD | -4USD | 0USD | -3,000USD |
| Free Cash Flow | -10,828,000USD | -8,418,000USD | -4,541,000USD | -3,375,000USD | -1,407,240USD | -75,000USD | — |
| Investments | -5,000USD | -22,000USD | 573,000USD | -524,000USD | — | — | — |
| Total Cashflows From Investing Activities | -14,000USD | -22,000USD | 573,000USD | -524,000USD | — | — | -28,000USD |
| Net Borrowings | -696,000USD | -250,000USD | 0USD | — | — | — | — |
| Total Cash From Financing Activities | 15,640,000USD | 5,104,000USD | 522,000USD | 2,752,000USD | 116,400,851USD | 126,701USD | 1,721,000USD |
| Issuance Of Capital Stock | 18,680,000USD | 3,054,000USD | 522,000USD | 2,749,000USD | — | — | — |
| Change In Cash | 4,805,000USD | -3,375,000USD | -3,664,000USD | -1,774,000USD | -12,757USD | 51,701USD | 782,000USD |
| Begin Period Cash Flow | 1,270,000USD | 4,645,000USD | 8,309,000USD | 10,083,000USD | 51,701USD | 10,083,000USD | — |
| End Period Cash Flow | 6,075,000USD | 1,270,000USD | 4,645,000USD | 8,309,000USD | 38,944USD | 51,701USD | 10,083,000USD |
| Other Cashflows From Investing Activities | -5,000USD | — | 78,000USD | — | — | — | -25,000USD |
| Other Cashflows From Financing Activities | 15,640,000USD | 2,300,000USD | 522,000USD | 2,752,000USD | -2,549,159USD | — | — |
| Unclassified Financing Cash Flow | -17,984,000USD | — | — | -2,749,000USD | 118,950,010USD | — | — |
| Change To Account Receivables | — | — | 18,000USD | -40,000USD | — | — | -97,000USD |
| Change To Liabilities | — | — | — | — | — | — | 55,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.